SGLT2 inhibitors reduce the risk of hospitalization for heart failure and amputation rate compared with incretin-based therapy in patients with diabetic foot disease: A nationwide population-based study

Name: SGLT2 inhibitors reduce the risk of hospitalization for heart failure and amputation rate compared with incretin-based therapy in patients with diabetic foot disease: A nationwide population-based study
Creator: Yi-Hsuan Lin
Published: 2023-11-13T07:35:12.300Z
Keywords: Diabetes, Heart Failure, Amputation

Lin, Yi-Hsuan

doi:10.17632/jdv9bjtnxw.1

SGLT2 inhibitors reduce the risk of hospitalization for heart failure and amputation rate compared with incretin-based therapy in patients with diabetic foot disease: A nationwide population-based study

Published: 13 November 2023| Version 1 | DOI: 10.17632/jdv9bjtnxw.1

Contributor:

Yi-Hsuan Lin

Description

supplementary table and figures

Files

Steps to reproduce

from NHIRD

SGLT2 inhibitors reduce the risk of hospitalization for heart failure and amputation rate compared with incretin-based therapy in patients with diabetic foot disease: A nationwide population-based study

Description

Files

Steps to reproduce

Categories

Licence